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ABSTRACT: In this present study, the analgesic activity of the aqueous extract of the leaves of Dichrostachy 
cinerea was investigated in mice using acetic acid-induced writhing and hot plate test, while the anti-inflammatory 
activity was investigated in rats using the carrageenan and dextran- induced paw edema. The extract (400, 800mg/kg) 
exhibited a dose dependent inhibition of abdominal writhing in mice compared to control. The effects of the extract 
were not significantly different from that of aspirin. The extract (800mg/kg) caused a significant (p<0.01) increase in 
pain threshold, at 60th minute post treatment in the hot plate test and the effects of the extract were lower than that of 
morphine (4mg/kg). The extract (800mg/kg) and indomethacin (10mg/kg) at 1st hour and 2nd - 4th hour produced 
inhibitions of the carrageenan-induced paw oedema versus control. The results also showed that the extract (800mg/kg) 
produced inhibition of dextran- induced paw edema between 2nd hour and 4th hour compared to control. Overall, our data 
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It is common knowledge that humans have relied on 
herbs and other natural products for the cure and 
management of various ailments over the years and 
the use of extracts from plant materials as relief for 
pain and inflammation dates as far back as 30 AD 
(Vane and Botting, 1987). Similarly, many medicinal 
plants are used in developing countries for the 
management of several medical conditions including 
those characterized by pain and inflammation 
(Adebayo et al., 2015). While several modern 
medicines are effective in treating pain and  
inflammatory disorders, their prolonged use may 
cause severe adverse effects, the most common being 
gastrointestinal bleeding and peptic ulcers (Vernerito 
et al., 2010). Hence, the need for the development of 
more effective pain medications devoid of adverse 
effects has become imperative and medicinal plants 
and herbs are potential sources from which such 
medications could be developed.  
 
D. cinerea is one medicinal plant that has been used 
in folkloric medicine in Nigeria for the treatment of 
syphilis, body pains and toothaches. It is popularly 
called ``dundu`` among the hausa speaking people of 
northern Nigeria and ``kora`` among the Yoruba 
speaking people of south western Nigeria (Gill, 
1992). D. cinerea (fabaceae) is a spiny deciduous 
shrub or small tree, up to 5-10m high with compound 
pinnate leaves (Kuber et al., 2009), and it is found in 
tropical and sub-tropical conditions (Mishra et al., 
2009). 
The chloroform extract of the leaves of D. cinerea 
has been demonstrated to possess antibacterial and  
analgesic effect (Mishra et al., 2009) and the saponin 
extract of the leaves has also been demonstrated to 
possess anti-inflammatory activity (Hassan et al., 
2012). Kuber et al., 2009 evaluated the 
neuropharmacolgical effects of the root of D. cinerea. 
These scientific evaluations, which used only one 
model of acute pain and inflammation, partly validate 
the medicinal usefulness of D.cinerea in folkloric 
medical management of painful and inflammatory 
conditions. However, the need to give more validity 
to its folkloric medicinal claims using more extensive 
model of acute pain and inflammation has become 
necessary. To this end, this present study was 
conducted to screen the aqueous extract of the leaves 
of D. cinerea for analgesic and anti-inflammatory 
activities using two acute models of pain and 
inflammation in mice and rats respectively. 
 
MATERIALS AND METHODS  
Drugs and chemicals: Carragenan, indomethacin, 
morphine, acetic acid and acetylsalicylic acid were 
all obtained from Sigma chemical Co. All drugs and 
chemicals were freshly prepared before use. 
Plant collection, identification and extraction: The 
fresh plant was collected from the premises of the 
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University of Benin, Benin City, Nigeria. The plant 
was duly identified and authenticated by Mr. 
Shasanya Olufemi of the Forestry Research Institute 
of  Nigeria, Ibadan (FRIN, Ibadan) where a 
herbarium specimen (FHI NO: 109986) was 
deposited for future reference. The young leaves 
were then carefully separated from the stem; air dried 
for 7 days and pulverized using an electric mill. The 
powered plant material (500g) was macerated in 4.5 
litres of distilled water at room temperature and 
filtered after 24h. The filtrate was concentrated to 
dryness over a water bath. The dried extract obtained 
(Yield=12.83%) was stored in airtight glass 
containers in the refrigerator at 4 C till required. 
 
Animal:  Swiss albino mice (25-35g) and wistar rats 
(190-300g) of either sex kept at the Animal Unit of 
the Department of Pharmacology and Toxicology, 
Faculty of Pharmacy, University of Benin, Benin 
City, Nigeria were used. The animals maintained 
under standard environmental conditions were 
allowed to acclimatize for two weeks and had free 
access to standard diet (Bendel Feeds and Flour Mill, 
Ewu, Edo State, Nigeria) and water ad libitum. 
Animals were exposed to natural lighting conditions 
and handled in accordance with the international 
principles guiding the use and handling of 
experimental animals (National Institute of Health, 
USA, 2002). 
 
Mouse writhing assay: The method described by 
Koster et al. (1959) was used. Mice were randomly 
divided into four groups of five animals per group. 
The extract (400-800mg/kg), normal saline (10ml/kg) 
or acetylsalicylic acid (100mg/kg) was administered 
orally to the mice according to their group 30 minutes 
before intraperitoneal injection of acetic acid 
(0.6%v/v in normal saline, 10ml/kg). Number of 
writhes, which consisted of constriction of the 
abdominal muscle together with a stretching of hind 
limbs, was cumulatively counted for 30minutes 
following acetic acid injection. Inhibition of pain was 





Where mean writhes (control) is the mean writhes of 
the normal saline treated animals and mean writhes 
(treated) is the mean writhes of the animal given 
acetylsalicylic acid or each dose of aqueous leave 
extract of D. cinerea 
 
Hot plate assay: Swiss albino mice of either sex 
screened for suitable reaction time, 24h before the 
experiment were used. The animals were randomly 
divided into four groups of five mice each. One hour 
before treatment the baseline hot plate latency of 
each mouse was taken. This represented the baseline 
latency before treatment. The extract (400-800mg/kg, 
orally), normal saline (10ml/kg, orally) or morphine 
(4mg/kg, i.p) were administered to the mice 
according to their group. One hour and thirty minutes 
after treatment with the extract, normal saline and 
morphine respectively, the response to nociceptive 
stimulus was measured with the hot plate 
analgesiometer (Ugo Basile, Italy) with the 
temperature maintained at 55 ± 1°C (Woolfe and 
Macdonald, 1944). A cut-off time of 60 seconds was 
adopted to prevent tissue damage.  The time between 
the placements of the mice and licking or biting of 
the hind paw or jumping was recorded as the index of 
response latency. Response latencies were taken at 30 
minutes intervals till 120minutes post treatment. 
 
Carrageenan-induced paw edema: Wistar rats were 
allotted into four groups of five rats each. Using a 
venier caliper, baseline measurement of the right hind 
paw thickness of each rat was taken. The rats were 
pretreated, orally, with extract (400,800mg/kg), 
indomethacin (10mg/kg) or normal saline (10ml/kg) 
according to their group. One hour later, edema was 
induced in the rats by injection of freshly prepared 
carrageenan (0.1ml, 1%w/v in normal saline) into the 
plantar aponeurosis of the right hind paw of each rat 
(Winter et al, 1962). Measurement of the thickness of 
the injected paw was repeated at hourly intervals for 
a maximum of four hours after carrageenan injection 
with the aid of a vernier caliper. 
 
Dextran- induced paw edema:  Wistar rats were 
allotted into four groups of five rats each. Using a 
plethysmometer the exact baseline right hind paw 
volume of each rat was measured. The rats were 
pretreated, orally, with normal saline (10ml/kg), 
extract (400,800mg/kg) or diphenhydramine 
(60mg/kg) according to their group. One hour later, 
edema was induced in the rats by injection of freshly 
prepared dextran (0.1ml, 1.5%w/v in normal saline) 
into the plantar aponeurosis of the right hind paw of 
each rat (Glauce et al., 1998). Measurement of the 
volume of the injected paw was repeated at hourly 
intervals for a maximum of four hours after dextran 
injection using a plethysmometer. 
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Statistical analysis: Statistical analysis was done 
using graph pad prism version 4. The data were 
analysed using one and two way analysis of variance 
(ANOVA) followed by turkey post hoc test. Data 
represent mean± SEM. Statistical significance was 
considered at p<0.05. 
 
RESULTS AND DISCUSSION 
The extract (400mg and 800mg) produced a 
significant (p<0.01) and dose-dependent inhibition of 
acetic acid induced writhes compared to normal 
saline control group. The inhibition of writhes 
produced by the extract (400mg/kg and 800mg/kg) 
was not significantly different from that of 
acetylsalicylic acid (100mg/kg) (Table 1). Acetic acid 
injected intraperitoneally is believed to act indirectly 
by inducing the release of prostaglandins and 
lipoxygenase products into the peritoneum which in 
turn stimulate the nociceptive neurons to produce 
writhes (Hunskaar and Hole, 1987). Acetic acid 
induced mouse writhing test is useful for the 
evaluation of mild analgesic non-steroidal anti-
inflammatory compounds for peripheral anti-
nociceptive or analgesic activity (Berkenkopf et al., 
1988). Thus, the significant inhibitory effect exerted 
by the extract on the acetic acid induced mouse 
writhing suggests that the extract has a peripheral 
analgesic effect. This finding is in consonance with 
earlier report which demonstrated the analgesic effect 
of the chloroform extract of D. cinerea leaves using 
the acetic acid induced mouse writhing model 
(Mishra et al., 2009).  
 
Table 1: Effect of aqueous extract of Dichrostachys cinerea on acetic acid induced writhing. 
Group  Dose (mg/kg) Mean writhes % inhibition 
Normal saline 
control 
10ml/kg 43.80 ± 9.2 - 
D . cinearea 400 19.0 ± 5.6** 56.6 
 800 13.40 ± 2.7** 69.4 
Acetylsalicylic acid 100 18.80 ± 2.9** 57.1 
Values are mean ± SEM **p<0.01 significantly different from control group (n=5) 
 
The extract only produced a significant (p<0.01) 
increase in latency time at a dose of 800mg/kg at the 
60
th
 minute compared to the control group. Morphine 
(4mg/kg) produced a significant (p<0.0001) increase 
in latency time from the 30
th
 to the 90
th
 minute (Table 
2). Centrally mediated nociception is often modeled 
using the thermal stimulus produced by the hot plate. 
Consequently, the hot plate test is often used to 
screen substances for central analgesic activity and 
centrally active analgesics increase reaction latency 
time of laboratory animals to thermally induced pain 
by the hot plate (Heidari et al., 2009). Thus, the 
significant elevation of the reaction latency time of 
the mice, 60minutes following administration of the 
extract (800mg/kg) suggests that the extract, at high 
doses may have a weak and short-lived central 
analgesic activity. 
. 
Table 2: Effect of aqueous extract of Dichrostachys cinerea on latency time in hot plate test in mice 
Group Dose 
(mg/kg) 
0min (baseline) 30min 60min 90min 120min 
Normal 
saline control 
- 3.96± 0.25 3.42 ± 0.44 5.70  ± 2.35 5.10 ± 1.05 4.30 ± 1.54 
D.cinerea 400 4.32± 0.36 7.96 ± 1.78 7.94 ± 1.33 5.68  ± 1.22 4.68 ± 0.62 
D.cinerea 800 4.36± 0.88 7.82 ± 1.05 13.42 ± 1.80** 10.52 ± 2.56 5.84 ± 1.72 
Morphine 4 5.20± 0.88 14.56±1.84**** 20.40±3.56**** 16.28±2.84**** 11.80 ± 2.16* 
Values are Mean time (Seconds) ± SEM *p<0.05, **p<0.01, ****p<0.0001 versus control group (n=5).  
 
The extract (400mg/kg) administered one hour prior 
to carrageenan injection caused a significant (p<0.01) 
inhibition of paw edema from the third hour 
following carrageenan injection compared to control. 
On the other hand 800mg/kg of the extract caused a 
significant (p<0.01 and p<0.0001 respectively) 
inhibition  of paw edema at 1 hour and 2- 4 hours  
following carrageenan injection and this was 
comparable to the inhibition of paw edema produced 
by standard anti-inflammatory drug- indomethacin 
(Figure 1). Carrageenan as a phlogistic agent is non-
antigenic and has no apparent systemic effect 
(Chakraborty et al, 2006). Carragenan induces acute 
inflammation and it is a suitable model for screening 
for non-steroidal anti-inflammatory drugs (Vinegar et 
al., 1969). Carrageenan-induced oedema is believed 
to involve three phases; the first phase occurs within 
one hour of carrageenan injection and it is attributed 
to the release of mast cell autacoids like histamine 
and serotonin. The second phase which occurs after 
1.5 hours following carrageenan injection is on 
account of the release of prostalgladins, arachidonic 
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acid byproducts and the continuity between phases 
one and two is due to the release of kinins (Vinegar et 
al, 1987). Also, neutrophil migration, release of 
oxygen free radicals and proteolytic enzymes are 
believed to be contributory to the development of the 
second phase (Boughton-smith et al., 1993). The 
extract (800mg/kg) significantly inhibited 
carrageenan-induced paw oedema in the first and 
second phases. Given that histamine induced 
microvascular leakage is believed to be responsible 
for the first phase of carrageenan induced 
inflammation (Kuriyama et al., 2000), the inhibition 
of the first phase of carrageenan induced 
inflammation by the extract (800mg/kg) suggests anti 
–histamine activity. The observation that the extract 
at a dose of 400mg/kg did not inhibit the first phase 
of carrageenan induced inflammation indicates that 
the extract may only possess anti-histamine activity 
at higher doses. Furthermore, the inhibition of the 
second phase of carrageenan induced inflammation, 
which corresponds to the phase of prostalgladin 
release, by the extract (400 and 800mg/kg), suggests 
an inhibitory effect on prostalgladin activity and 
activity of other cycloxygenase products because 
carrageenan inflammatory model essentially reflects 
the actions of prostalgladins (Ferreira et al., 1974). 
 
 
Fig.1: Effect of aqueous extract of Dichrostachys cinerea on carrageenan induced paw edema in rats. Values are 
mean ± SEM **p<0.01, ***p<0.0001 versus control. (n=5). 
 
The extract (800mg/kg) caused a significant 
inhibition of dextran induced paw edema between the 
second hour and fourth hour following dextran 
injection compared to control. On the other hand, the 
extract at 400mg/kg produced no significant 
inhibition of dextran induced paw edema (Figure 2).  
Given that dextran induced paw edema is mediated 
by histamine and serotonin released from the mast 
cells which in turn caused marked vasodilation, 
increased permeability and slowing of blood flow in 
the vascular system (Pearce, 1986), the inhibition of 
dextran induced paw edema produced by the extract 
indicates that the extract may possess anti- histamine 
anti – serotonin activities 
 
Fig.2: Effect of aqueous extract of Dichrostachys cinerea on dextran induced paw edema in rats.  
Values are mean ± SEM *p<0.01, ***p<0.0001 versus control. (n=5). 
 
On the basis of the findings from this study, it is 
concluded that the aqueous extract of D. cinerea 
possesses analgesic effects probably mediated, solely, 
by peripheral mechanisms via the inhibition of 
prostalgladin activity and anti-inflammatory effects 
probably mediated by peripheral mechanisms via the 
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inhibition of cycloxygenase and 
histaminergic/serotonergic activities. These results 
therefore further support the folkloric claim of the 
effectiveness of the leaf extract of D. cinerea for the 
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